Standards; Pharmaceutical/API Drug Impurities/Metabolites;
应用:
N5-[4,5-Dihydro-5-oxo-4-[(2S,3R)-2,3,4-trihydroxybutyl]-1H-imidazol-2-yl]-L-ornithine is an advanced glycation end-products that can be used to predict loss of renal function in American Indians with type 2 diabetes.
您的位置：![N5-[4,5-Dihydro-5-oxo-4-[(2S,3R)-2,3,4-trihydroxybutyl]-1H-imidazol-2-yl]-L-ornithine](/uploads/allimg/191123/1_1123133AYT0.png "N5-[4,5-Dihydro-5-oxo-4-[(2S,3R)-2,3,4-trihydroxybutyl]-1H-imidazol-2-yl]-L-ornithine")
